Breast Cancer News and Research

Latest Breast Cancer News and Research

New York Academy of Sciences and Zeltia to host marine drug discovery forum on May 20, 2011

Substances produced by living organisms found in nature-so-called "natural products"-have played a critical role in the development of drugs for life-threatening conditions. The anticancer agent Taxol was sourced from a plant, penicillin from a fungus, and a number of recent breakthroughs have resulted in the development and approval of anticancer drugs derived from marine sources such as coral and sponges.

16 May 2011

ZIOPHARM submits IND with FDA for Ad-RTS-IL-12 Phase I study in cancer

ZIOPHARM Oncology, Inc., a drug development company employing small molecule and synthetic biology approaches to cancer therapy, today announced that it has submitted an Investigational New Drug (IND) application to the U.S. Food & Drug Administration (FDA) to begin clinical study of Ad-RTS-IL-12, a novel DNA-based therapeutic candidate.

13 May 2011

Rethink praises Ontario's decision to provide breast cancer patients with access to Herceptin

Today, Rethink Breast Cancer (Rethink) applauds the Ontario government's decision to provide breast cancer patients with tumours less than or equal to 1 cm access to the revolutionary drug Herceptin under the new Evidence Building Program.

13 May 2011

ACS, PGi celebrate 10 years of partnership on key cancer initiatives

Atlanta-based PGi, a global leader in real-time, meeting solutions, and the American Cancer Society are celebrating 10 years of working together on key Society initiatives, including the ACS signature cancer fundraising event, Relay for Life.

13 May 2011

ACR to honor UCLA cancer researcher with Gold Medal for radiology work

Dr. Lawrence W. Bassett, a nationally renowned expert with more than 35 years experience in breast imaging, has been chosen to receive the Gold Medal by the American College of Radiology, the organization's highest honor given for distinguished and extraordinary service in the field of radiology.

13 May 2011

Coffee provides protections from a type of breast cancer: Study

For the study they compared coffee consumption in postmenopausal women with breast cancer and women of the same age without cancer, they found those who drank five or more cups of java a day showed a 0.43 times lower risk of estrogen-receptor negative cancers. Around one in four women diagnosed with breast cancer will have estrogen-receptor negative breast cancer, which is often resilient to drug treatment and requires intensive chemotherapy.

12 May 2011

Biocept's paper describes identification of different CTC phenotypes in cancer patients

Biocept, Inc., a privately-held laboratory testing company focused on the detection, enumeration and analysis of circulating tumor cells (CTCs) in cancer patients, today announced the publication of a paper describing the identification of different CTC phenotypes using its proprietary Cell Enrichment and Extraction platform.

12 May 2011

U-Systems to exhibit new version of somo•v automated breast ultrasound at SBI Meeting

U-Systems, the leader in automated breast ultrasound, will showcase significant upgrades to its somo•v Automated Breast Ultrasound System at the 10th Post Graduate Course of the Society of Breast Imaging Meeting, in San Antonio, May 18- 21.

12 May 2011

Researchers look for surrogate endpoints to predict early benefit of cancer drugs

Great hopes are always placed in new cancer therapies. However, whether new surgical techniques, drugs or radiation therapies actually prolong the life of cancer patients, or even cure them, can often only be reliably assessed after several years' of testing. Researchers are therefore looking for proxy markers that after initiation of cancer therapy can reliably predict as quickly as possible whether the treatment has a benefit.

12 May 2011

INESC Porto, FEUP develop software to automatically analyse and validate mammograms

INESC Porto and FEUP developed software to automatically analyse and validate mammograms. The software, Semantic PACS, can be incorporated into hospital IT systems and it categorises each new mammography using automatic descriptive methods and search methods that compare the semantic contents of the images stored.

12 May 2011

INESC Porto, FC and FMUP to hold international seminar on breast cancer local treatment

The international seminar "Turning Subjective Into Objective: Cosmetic Breast Assessment of Local Treatment" will take place on 13th May starting at 9.15am. The event is organised by the Champalimaud Foundation, the Faculty of Medicine of the University of Porto and the Institute for Systems and Computer Engineering of Porto.

12 May 2011

ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, the Centre Léon Bérard, the major cancer research and treatment center for the Rhône-Alpes region of France, and ImmunID Technologies SAS, a diagnostic company specialized in innovative immunomonitoring tests and services, today announced initiation of a Phase IIa clinical trial that will evaluate multiple combinations of recombinant human interleukin-7, the investigational multifunctional cytokine under development by Cytheris, and a chemotherapeutic agent, XELODA, in the treatment of metastatic breast cancer.

11 May 2011

Women with invasive breast cancer can benefit from new genomic test

A new genomic test combining multiple signatures - a patient's estrogen receptor status, endocrine therapy response, chemotherapy resistance and sensitivity - shows promise as a predictor of chemotherapy response and survival benefit in women with invasive breast cancer, according to research led by The University of Texas MD Anderson Cancer Center.

11 May 2011

Genetic test to identify women at higher risk of breast cancer could reduce risks associated with screening

Calculating individual genetic cancer risk and taking age into account could mean fewer women would need to be screened for breast cancer, according to research published in the British Journal of Cancer1.

11 May 2011

Breast cancer and unhealthy lifestyle choices

Figures have shown that more than one in five British women is classified as obese, and research has found those affected are almost 50 per cent more likely to die from breast cancer than women carrying less weight. Studies have shown that obesity in women leads to changes in sex-hormone levels that may trigger estrogen-dependent tumors, which form the majority of cases. Drinking just one large glass of wine a day also increases the chance of developing breast cancer by a fifth, say experts. It is thought alcohol raises levels of estrogen in the body.

11 May 2011

Coffee consumption can reduce risk of ER-negative breast cancer in women

Recently published research shows that coffee drinkers enjoy not only the taste of their coffee but also a reduced risk of cancer with their cuppa. More detailed research published today in BioMed Central's open access journal Breast Cancer Research shows that drinking coffee specifically reduces the risk of antiestrogen-resistant estrogen-receptor-negative breast cancer.

11 May 2011

Seven-time Tour de France champion to raise funds for CBCF's cancer research initiatives

Cancer survivor and seven-time Tour de France champion, Lance Armstrong, will be in Calgary September 8 to support the work of the Canadian Breast Cancer Foundation - Prairies/NWT Region during the Foundation's 25th anniversary.

10 May 2011

Rapid blood-based test can determine patients with SLE

"At present, it can take up to a year before a patient is diagnosed with SLE. This is because the symptoms are diffuse and are often mistaken for other diseases. However, with this blood-based test, it is possible to determine quickly whether someone has the disease or not", says Christer Wingren, associate professor in Immunotechnology at CREATE Health, Lund University.

10 May 2011

Treatment with estrogen-lowering drugs shrinks tumors and reduces mastectomy rates in breast cancer patients

In the first large trial of its kind in the United States, researchers have shown that estrogen-lowering drugs can shrink tumors and reduce mastectomy rates for patients with stage 2 or 3 breast cancer.

10 May 2011

Acceleron presents RAP-661 preclinical data in osteopenic mice at international meeting

Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases, presented preclinical data highlighting the significant anabolic bone effects in normal and osteopenic mice of RAP-661.

10 May 2011

Breast Cancer News and Research

Latest Breast Cancer News and Research

New York Academy of Sciences and Zeltia to host marine drug discovery forum on May 20, 2011

ZIOPHARM submits IND with FDA for Ad-RTS-IL-12 Phase I study in cancer

Rethink praises Ontario's decision to provide breast cancer patients with access to Herceptin

ACS, PGi celebrate 10 years of partnership on key cancer initiatives

ACR to honor UCLA cancer researcher with Gold Medal for radiology work

Coffee provides protections from a type of breast cancer: Study

Biocept's paper describes identification of different CTC phenotypes in cancer patients

U-Systems to exhibit new version of somo•v automated breast ultrasound at SBI Meeting

Researchers look for surrogate endpoints to predict early benefit of cancer drugs

INESC Porto, FEUP develop software to automatically analyse and validate mammograms

INESC Porto, FC and FMUP to hold international seminar on breast cancer local treatment

ImmunID, Centre Léon Bérard and Cytheris commence CYT107-XELODA Phase IIa trial in metastatic breast cancer

Women with invasive breast cancer can benefit from new genomic test

Genetic test to identify women at higher risk of breast cancer could reduce risks associated with screening

Breast cancer and unhealthy lifestyle choices

Coffee consumption can reduce risk of ER-negative breast cancer in women

Seven-time Tour de France champion to raise funds for CBCF's cancer research initiatives

Rapid blood-based test can determine patients with SLE

Treatment with estrogen-lowering drugs shrinks tumors and reduces mastectomy rates in breast cancer patients

Acceleron presents RAP-661 preclinical data in osteopenic mice at international meeting

Industry Focus eBook - Oncology (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Breast Cancer News and Research

Latest Breast Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in